A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
Completed · Phase 1
Conditions studied: Glaucoma, Ocular Hypertension
In brief
To evaluate the steady-state systemic plasma concentrations of latanoprost acid following administration of latanoprost 0.005% (1.5 ug) in pediatric and adult subjects with glaucoma or ocular hypertension.
Key facts
- Study ID
- NCT00638742
- Run by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- People needed
- 47
- Starts
- 2008-05-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2021-02-02
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- This study will enroll pediatric and adult subjects with glaucoma or ocular hypertension receiving treatment with latanoprost in either one or both eyes for at least two weeks.
- The pediatric subjects will be grouped by age (0 to <3 years, 3 to <12 years, 12 to 18 years).
You may not qualify if…
- Ocular inflammation/infection or a history of ocular inflammation/infection within 3 months prior to the screening visit.
- History of ocular trauma or surgery in either eye within 14-days of the screening visit.
- Use of continuous wear contact lenses.
Where it is running
- Pfizer Investigational Site — Artesia, California, United States
- Pfizer Investigational Site — Atlanta, Georgia, United States
- Pfizer Investigational Site — Atlanta, Georgia, United States
- Pfizer Investigational Site — North Dartmouth, Massachusetts, United States
- Pfizer Investigational Site — Minneapolis, Minnesota, United States
- Pfizer Investigational Site — Durham, North Carolina, United States
- Pfizer Investigational Site — Koebenhavn OE, Denmark
- Pfizer Investigational Site — Catania, Italy
- Pfizer Investigational Site — Coimbra, Portugal
- Pfizer Investigational Site — Lisbon, Portugal
- Pfizer Investigational Site — Mayfair West, South Africa
- Pfizer Investigational Site — Madrid, Spain
- Pfizer Investigational Site — Madrid, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.